Marshall Wace
TYRA icon

Marshall Wace’s Tyra Biosciences TYRA Stock Holding History

Marshall Wace’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6M Buy
583,133
+385,385
+195% +$12.7M 0.01% 755
2026
Q1 		$7.57M Sell
197,748
-514,143
-72% -$16.6M 0.01% 1100
2025
Q4 		$18.7M Buy
711,891
+109,876
+18% +$2.02M 0.02% 653
2025
Q3 		$8.42M Buy
602,015
+173,907
+41% +$1.98M 0.01% 982
2025
Q2 		$4.1M Buy
428,108
+47,408
+12% +$450K ﹤0.01% 1240
2025
Q1 		$3.54M Buy
380,700
+326,623
+604% +$4.23M ﹤0.01% 1210
2024
Q4 		$752K Buy
54,077
+34,463
+176% +$625K ﹤0.01% 1871
2024
Q3 		$461K Buy
+19,614
New +$412K ﹤0.01% 1946
2024
Q2 		– Sell
-19,643
Closed -$322K – 2980
2024
Q1 		$322K Sell
19,643
-10,358
-35% -$170K ﹤0.01% 2086
2023
Q4 		$416K Buy
+30,001
New +$388K ﹤0.01% 1785

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Marshall Wace's TYRA Position: Q2 2026 in Review

Marshall Wace increased its Tyra Biosciences (TYRA) stake by 195% in Q2 2026, buying an estimated $12.7M and bringing the position to 583,133 shares worth $18.6M. The position accounts for 0.01% of the portfolio, ranked #755.

Marshall Wace first reported a position in TYRA in Q4 2023 and has held it in 10 quarters since. The position peaked at $18.7M in Q4 2025. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Marshall Wace held 583,133 shares of Tyra Biosciences worth $18.6M as of Q2 2026.
  • Marshall Wace bought 385,385 Tyra Biosciences shares in Q2 2026, an estimated $12.7M.
  • Tyra Biosciences made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #755 holding.
  • Marshall Wace first reported a position in Tyra Biosciences in Q4 2023 and has held it in 10 quarters since.
  • Marshall Wace's Tyra Biosciences position peaked at $18.7M in Q4 2025.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.